[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2017 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 27.13%
YoY- 9.88%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 467,987 474,312 480,710 483,976 312,940 318,542 317,210 29.50%
PBT 51,796 51,961 49,528 44,704 31,479 33,573 35,328 28.96%
Tax -9,696 -11,518 -11,118 -10,232 -4,653 -9,580 -11,790 -12.19%
NP 42,100 40,442 38,410 34,472 26,826 23,993 23,538 47.19%
-
NP to SH 42,492 40,829 38,434 34,472 27,115 25,156 24,692 43.46%
-
Tax Rate 18.72% 22.17% 22.45% 22.89% 14.78% 28.53% 33.37% -
Total Cost 425,887 433,869 442,300 449,504 286,114 294,549 293,672 28.03%
-
Net Worth 479,809 474,230 463,071 463,071 454,703 451,913 446,334 4.92%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 23,711 - 13,947 - 18,132 - 13,947 42.30%
Div Payout % 55.80% - 36.29% - 66.87% - 56.49% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 479,809 474,230 463,071 463,071 454,703 451,913 446,334 4.92%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 9.00% 8.53% 7.99% 7.12% 8.57% 7.53% 7.42% -
ROE 8.86% 8.61% 8.30% 7.44% 5.96% 5.57% 5.53% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 167.76 170.03 172.32 173.49 112.18 114.19 113.71 29.50%
EPS 15.09 14.49 13.76 13.72 9.62 8.60 8.44 47.15%
DPS 8.50 0.00 5.00 0.00 6.50 0.00 5.00 42.30%
NAPS 1.72 1.70 1.66 1.66 1.63 1.62 1.60 4.92%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 48.65 49.31 49.97 50.31 32.53 33.11 32.98 29.49%
EPS 4.42 4.24 4.00 3.58 2.82 2.62 2.57 43.40%
DPS 2.46 0.00 1.45 0.00 1.88 0.00 1.45 42.11%
NAPS 0.4988 0.493 0.4814 0.4814 0.4727 0.4698 0.464 4.92%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 2.53 2.20 2.25 2.31 1.98 2.06 2.04 -
P/RPS 1.51 1.29 1.31 1.33 1.76 1.80 1.79 -10.69%
P/EPS 16.61 15.03 16.33 18.69 20.37 22.84 23.05 -19.57%
EY 6.02 6.65 6.12 5.35 4.91 4.38 4.34 24.30%
DY 3.36 0.00 2.22 0.00 3.28 0.00 2.45 23.36%
P/NAPS 1.47 1.29 1.36 1.39 1.21 1.27 1.28 9.63%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 -
Price 2.97 2.20 2.03 2.32 2.23 2.10 2.14 -
P/RPS 1.77 1.29 1.18 1.34 1.99 1.84 1.88 -3.92%
P/EPS 19.50 15.03 14.73 18.77 22.94 23.29 24.18 -13.32%
EY 5.13 6.65 6.79 5.33 4.36 4.29 4.14 15.32%
DY 2.86 0.00 2.46 0.00 2.91 0.00 2.34 14.27%
P/NAPS 1.73 1.29 1.22 1.40 1.37 1.30 1.34 18.51%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment